tazarotene has been researched along with Pachyonychia Congenita in 1 studies
tazarotene: a topical acetylenic retinoid; a topical kerytolytic
tazarotene : The ethyl ester of tazarotenic acid. A prodrug for tazarotenic acid, it is used for the treatment of psoriasis, acne, and sun-damaged skin.
Pachyonychia Congenita: A group of inherited ectodermal dysplasias whose most prominent clinical feature is hypertrophic nail dystrophy resulting in PACHYONYCHIA. Several specific subtypes of pachyonychia congenita have been associated with mutations in genes that encode KERATINS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daroach, M | 1 |
| Dogra, S | 1 |
| Bhattacharjee, R | 1 |
| Tp, A | 1 |
| Smith, F | 1 |
| Mahajan, R | 1 |
1 review available for tazarotene and Pachyonychia Congenita
| Article | Year |
|---|---|
Pachyonychia congenita responding favorably to a combination of surgical and medical therapies.
Topics: Administration, Topical; Combined Modality Therapy; Female; Genetic Predisposition to Disease; Human | 2019 |